Alpine Global Management, LLC Vbi Vaccines Inc Transaction History

Alpine Global Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$1.27 - $2.47 $70,168 - $136,469	-55,251 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.21 - $3.22 $90,101 - $131,279	40,770 Added 281.54%	55,251 $129,000
Q2 2021 Aug 13, 2021	BUY	$2.61 - $4.17 $37,795 - $60,385	14,481 New	14,481 $49,000
Q3 2018 Nov 15, 2018	SELL	$1.75 - $2.93 $141,018 - $236,105	-80,582 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$2.75 - $3.85 $221,600 - $310,240	80,582 New	80,582 $222,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Global Management, LLC with notifications on news.